共 152 条
[1]
Loehberg CR(2013)Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis Breast Cancer Res Treat 138 899-908
[2]
Almstedt K(2014)Trastuzumab administration in patients with metastatic breast cancer – experience of a large University Breast Center Geburtshilfe Frauenheilkd 74 563-8
[3]
Jud SM(2001)Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer Cancer Res 61 5345-8
[4]
Haeberle L(2002)Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites Ann Oncol 13 1036-43
[5]
Fasching PA(2003)Thor AD: erbB-2 (HER-2) and breast cancer progression Appl Immunohistochem Mol Morphol 11 214-21
[6]
Hack CC(2008)HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy Int J Cancer 122 999-1004
[7]
Hartkopf A(2013)The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse Breast Cancer Res Treat 138 509-17
[8]
Brendel M(2010)HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial Breast Cancer Res Treat 124 403-12
[9]
Wallwiener M(2012)HER2-positive DTCs/CTCs in breast cancer Recent Results Cancer Res 195 203-15
[10]
Taran FA(2012)Clinical implications of the detection of circulating tumor cells in breast cancer patients Biomark Med 6 109-18